Global Health Limited (MEDANTA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Global Health Limited (MEDANTA) has a cash flow conversion efficiency ratio of 0.032x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs858.20 Million ≈ $9.28 Million USD) by net assets (Rs26.54 Billion ≈ $287.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Global Health Limited - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Global Health Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Global Health Limited total liabilities for a breakdown of total debt and financial obligations.
Global Health Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Global Health Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Legend Biotech Corp
NASDAQ:LEGN
|
0.028x |
|
Enerjisa Enerji AS
IS:ENJSA
|
0.063x |
|
Beijing BDStar Navigation Co Ltd
SHE:002151
|
0.001x |
|
KB Home
NYSE:KBH
|
0.079x |
|
Navan, Inc. Class A Common Stock
NASDAQ:NAVN
|
0.029x |
|
Towne Bank
NASDAQ:TOWN
|
0.048x |
|
Ningxia Orient Tantalum Industry Co Ltd
SHE:000962
|
-0.065x |
|
Xenon Pharmaceuticals Inc
NASDAQ:XENE
|
-0.140x |
Annual Cash Flow Conversion Efficiency for Global Health Limited (2019–2025)
The table below shows the annual cash flow conversion efficiency of Global Health Limited from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Global Health Limited.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs33.88 Billion ≈ $366.35 Million |
Rs6.24 Billion ≈ $67.46 Million |
0.184x | -12.59% |
| 2024-03-31 | Rs29.06 Billion ≈ $314.23 Million |
Rs6.12 Billion ≈ $66.19 Million |
0.211x | -20.64% |
| 2023-03-31 | Rs24.28 Billion ≈ $262.60 Million |
Rs6.45 Billion ≈ $69.70 Million |
0.265x | +37.81% |
| 2022-03-31 | Rs16.16 Billion ≈ $174.77 Million |
Rs3.11 Billion ≈ $33.66 Million |
0.193x | +10.13% |
| 2021-03-31 | Rs13.82 Billion ≈ $149.50 Million |
Rs2.42 Billion ≈ $26.15 Million |
0.175x | +34.82% |
| 2020-03-31 | Rs13.50 Billion ≈ $145.95 Million |
Rs1.75 Billion ≈ $18.93 Million |
0.130x | +11.84% |
| 2019-03-31 | Rs13.31 Billion ≈ $143.93 Million |
Rs1.54 Billion ≈ $16.69 Million |
0.116x | -- |
About Global Health Limited
Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emerg… Read more